Non-Alcoholic Fatty Liver Disease Special Interest Group 

The Non-Alcoholic Fatty Liver Disease Special Interest Group (SIG) is linked to the Metabolic CRN topic area. The SIG lead is Dr Stuart McPherson (elected February 2022) of Newcastle upon Tyne Hospitals NHS Foundation Trust. If anyone wishes to join the group please contact the BASL Secretariat on paula@basl.org.uk.  

Mission

To understand, prevent and treat NAFLD, and to reduce its impact on health as well as health services.

Aims

To promote and support the development, conduct and delivery of research activity related to NAFLD.

To disseminate innovations and best practices in clinical services related to NAFLD.

To involve patient representatives in the activities of the SIG.

To lead, contribute and participate in the development of educational activities related to NAFLD.

To engage with pharma regarding research and educational activities related to NAFLD.

To respond on behalf of BASL to national or international organisations on issues related to NAFLD.

 

Quality standards for the management of NAFLD

Overview

The BSG/BASL NAFLD special interest group has developed a series of evidence-based quality standard recommendations, with the aim of improving the care of people with NAFLD. It is known that NAFLD is common, affecting 25% of the UK population and management of the condition is variable. Individuals with NAFLD have an increased risk of overall mortality compared with the general population, and common causes of death include cardiovascular disease, malignancy and liver-related complications. A holistic approach is therefore needed to address liver disease, as well as cardio-metabolic risk factors.

The recommendations were developed using a modified Delphi process by a multidisciplinary group of 29 individuals from all disciplines involved in the management of people with NAFLD, and cover: 1. Management of people with, or at risk of, NAFLD before the gastroenterology or liver clinic; 2. Assessment and investigations in secondary care; 3. Management in secondary care. We have also developed 11 auditable key performance indicators (KPIs) to enable service to review the care of their patients and benchmark their practice.

Manuscript and summary documents

The full manuscript can be found here https://www.sciencedirect.com/science/article/pii/S2468125322000619?dgcid=author. (Free access to the manuscript will be available for 50 days from Friday 28 April 2022.)

Click here for the Download Summary of the NAFLD quality standard recommendations for website_l.pdf

 

 Resources

Annual reports
Annual report 2018-19 -  Download Annual report_2018-19_NAFLD SIG.pdf.

1st meeting - 11 January 2019
Agenda - Download NAFLD SIG _Agenda 110119.pdf.

2nd meeting - 14 June 2019
Agenda - Download Agenda_14 June 2019.pdf.

Presentation on NAFLD: A diabetologist's view, Chris Byrne, University of Southampton & Southampton NIHR BRC, University Hospital Southampton - Download Management of diabetes in patients with NASH_BASL.pdf

Presentations on chronic liver diseases: GP view:

3rd meeting - 28 February 2020
Agenda - Download Agenda_28 February 2020_FINAL.pdf.
Meeting report -  Download Report_28 February 2020.pdf.

NAFLD bioresource
Philip Newsome, University of Brimingham - Download NAFLD BioResource_June 2019.pdf.

Download NAFLD BioResource_Blog.pdf.


Join Basl - BASL Membership covers membership to BASL and all of it
 
BASL Events - BASL and the BASL Sub Groups run an exciting and varied calendar of educational events throughout the year, as well as endorsing other not to miss events. Click here to Book Now.